Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

15
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
15
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

18
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
18
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

16
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
16
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

15
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
15
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

809
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
809

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Placental growth factor (PLGF)-based testing to help diagnose suspected pre-eclampsia: a systematic review and economic evaluation.

Health technology assessment (Winchester, England)·2026
Same author

Evaluation of a supermarket placement strategy to nudge healthier dietary habits: synopsis of the WRAPPED study.

Public health research (Southampton, England)·2026
Same author

A multi-cohort evaluation of a curriculum-aligned, oncology-focused chatbot in pharmacy education.

Currents in pharmacy teaching & learning·2026
Same author

Cancer Therapy-Induced Cardiotoxicity: A Narrative Review.

Pharmacotherapy·2026
Same author

Delayed presentation of pembrolizumab-induced SJS-TEN overlap syndrome.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2025
Same author

Targeting TROP2 Across Solid Tumors: The Clinical Profile and Role of Datopotamab Deruxtecan.

The Annals of pharmacotherapy·2025

Related Experiment Video

Updated: Aug 9, 2025

An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery
06:40

An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery

Published on: June 8, 2021

2.5K

Perioperative Anticoagulation in Patients with Cancer.

Reshma R Nair1, Zachery Halford2, William F Towers3

  • 1Mercyhealth Family Medicine Residency Program-Janesville, Janesville, WI, USA.

Current Oncology Reports
|February 22, 2023
PubMed
Summary

Managing perioperative anticoagulation in cancer patients is complex. This review summarizes new evidence and strategies for optimal patient care, emphasizing individualized risk assessment for thrombosis and bleeding.

Keywords:
AnticoagulationBridgingCancerMalignancyPerioperative managementThromboprophylaxis

More Related Videos

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.5K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.0K

Related Experiment Videos

Last Updated: Aug 9, 2025

An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery
06:40

An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery

Published on: June 8, 2021

2.5K
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.5K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.0K

Area of Science:

  • Oncology
  • Hematology
  • Anesthesiology

Background:

  • Managing anticoagulation in cancer patients undergoing surgery presents unique challenges.
  • Existing evidence on perioperative anticoagulation for cancer patients is limited.
  • Cancer and its treatments significantly influence risks of thrombosis and bleeding.

Purpose of the Study:

  • To provide an overview of current evidence and strategies for perioperative anticoagulation management in cancer patients.
  • To guide clinicians in optimizing care for this complex patient population.
  • To highlight the importance of a patient-specific approach.

Main Methods:

  • A comprehensive review of recent literature and clinical guidance.
  • Analysis of new evidence concerning anticoagulation management in cancer patients.
  • Synthesis of information to address thrombotic and bleeding risks.

Main Results:

  • New evidence provides updated insights into managing perioperative anticoagulation in cancer.
  • Effective management requires careful consideration of cancer-specific and treatment-related factors.
  • Individualized patient assessment is crucial for balancing thrombotic and bleeding risks.

Conclusions:

  • Perioperative anticoagulation in cancer patients necessitates a nuanced, patient-tailored strategy.
  • Clinicians must integrate disease and treatment factors to mitigate risks.
  • Optimal care hinges on thorough, individualized risk-benefit assessments.